Comparison of cardiovascular outcomes between SGLT2 inhibitors in diabetes mellitus

Abstract Background There have been scarce data comparing cardiovascular outcomes between individual sodium-glucose cotransporter-2 (SGLT2) inhibitors. We aimed to compare the subsequent cardiovascular risk between individual SGLT2 inhibitors. Methods We analyzed 25,315 patients with diabetes mellit...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yuta Suzuki, Hidehiro Kaneko, Akira Okada, Hidetaka Itoh, Satoshi Matsuoka, Katsuhito Fujiu, Nobuaki Michihata, Taisuke Jo, Norifumi Takeda, Hiroyuki Morita, Kentaro Kamiya, Atsuhiko Matsunaga, Junya Ako, Koichi Node, Hideo Yasunaga, Issei Komuro
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2022-05-01
Edice:	Cardiovascular Diabetology
Témata:	SGLT2 inhibitor Cardiovascular disease Diabetes mellitus
On-line přístup:	https://doi.org/10.1186/s12933-022-01508-6
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!